Timothy F. Cloughesy

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.6Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

Cancer Cell(2023)10.1016/j.ccell.2023.05.001

Top 6%

3.5DataRank

Top 6%180 citations

Danielle Morrow, Nicholas Bayley, Elízabeth Fernández, Jennifer J. Salinas, Christopher Tse +13 more

Papers

Driven by 79 papers — median percentile 11. Top paper: “Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial”.

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0611

N/A

4.8DataRank · unranked

264 citations

Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú +16 more

CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis

Cancer Cell(2023)10.1016/j.ccell.2023.05.001

Top 6%

3.5DataRank

Top 6%180 citations

Danielle Morrow, Nicholas Bayley, Elízabeth Fernández, Jennifer J. Salinas, Christopher Tse +13 more

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

Nature Communications(2024)10.1038/s41467-024-48073-y

N/A

1.5DataRank · unranked

65 citations

Willy Hugo, Lu Sun, Joseph Antonios, Alex Lee, Lizhong Ding +10 more

Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04088-3

N/A

0.782DataRank · unranked

16 citations

Jacob Schlossman, Soroush Shabani, Catalina Raymond, Hiroyuki Tatekawa, Lauren E. Abrey +10 more

Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort

Nature Communications(2024)10.1038/s41467-024-54326-7

N/A

0.730DataRank · unranked

37 citations

Lu Sun, Gilbert C. Youssef, Raymond Y. Huang, Gang Li, Jiyoon Kim +31 more

Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients

Research Square(2023)10.21203/rs.3.rs-3287211/v1

N/A

0.125DataRank · unranked

1 citations

Richard G. Everson, Willy Hugo, Lu Sun, Joseph Antonios, Alex Lee +10 more

Leveraging Physics-Based Synthetic MR Images and Deep Transfer Learning for Artifact Reduction in Echo-Planar Imaging

American Journal of Neuroradiology(2025)10.3174/ajnr.a8566

Top 78%

0.104DataRank

Top 78%1 citations

Jingwen Yao, Bryan Clifford, Thorsten Feiweier, Sonoko Oshima, Donatello Telesca +7 more

Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials

Neuro-Oncology(2020)10.1093/neuonc/noaa253

N/A

0DataRank · unranked

19 citations

Matthew S. Brown, Jerrold L. Boxerman, Elizabeth R. Gerstner, Timothy J. Kaufmann, Patricia E. Cole +10 more

Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03407-w

N/A

0DataRank · unranked

18 citations

Jingwen Yao, Jacob Schlossman, Catalina Raymond, Matthew Ji, Hiroyuki Tatekawa +8 more

Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.247411

N/A

0DataRank · unranked

17 citations

Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda, Hiroyuki Uetani +9 more

Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa009

N/A

0DataRank · unranked

13 citations

Blaine S.C. Eldred, Regina Liu, Sean T. Pianka, Donna Molaie, Bryan M. Kevan +14 more

Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study

Scientific Reports(2020)10.1038/s41598-020-68733-5

N/A

0DataRank · unranked

41 citations

Akifumi Hagiwara, Catalina Raymond, Soroush Shabani, Whitney B. Pope, Noriko Salamon +7 more

Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa112

N/A

0DataRank · unranked

6 citations

Sameer Kejriwal, Samasuk Thammachantha, Courtney Duong, Adrián Murillo, Lynn K. Gordon +6 more

Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2521

N/A

0DataRank · unranked

4 citations

Raymond Y. Huang, Javier Villanueva‐Meyer, Mary Jane Lim-Fat, Elizabeth George, Bryan Iorgulescu +13 more

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3615

N/A

0DataRank · unranked

2 citations

Sylvia C. Kurz, Rohinton S. Tarapore, Ashley Sumrall, Nicholas Butowski, Rebecca A. Harrison +15 more

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Nature Communications(2021)10.1038/s41467-021-26940-2

N/A

0DataRank · unranked

264 citations

Lu Sun, Aaron Mochizuki, Jeremy Reynoso, Joey Orpilla, Frances Chow +9 more

Leveraging external data in the design and analysis of clinical trials in neuro-oncology

The Lancet Oncology(2021)10.1016/s1470-2045(21)00488-5

N/A

0DataRank · unranked

85 citations

Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes‐Rivera, Mei‐Yin C. Polley +14 more

Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1

Nature Communications(2021)10.1038/s41467-021-24293-4

N/A

0DataRank · unranked

28 citations

Alphonsus H. C. Ng, Frances Chow, Richard G. Everson, Beth A. Helmink, Michael T. Tetzlaff +6 more

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors

Neuro-Oncology(2021)10.1093/neuonc/noab276

N/A

0DataRank · unranked

26 citations

Talia C. Oughourlian, Nicholas S. Cho, Jacob Schlossman, Chencai Wang, Jingwen Yao +13 more

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET

Cancer Imaging(2021)10.1186/s40644-021-00396-5

N/A

0DataRank · unranked

19 citations

Akifumi Hagiwara, Hiroyuki Uetani, Shadfar Bahri, Catalina Raymond, Albert Lai +7 more

Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile?

Neuro-Oncology(2021)10.1093/neuonc/noab006

N/A

0DataRank · unranked

9 citations

Timothy F. Cloughesy, Andrew B. Lassman

“Aerobic glycolytic imaging” of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging

NeuroImage Clinical(2021)10.1016/j.nicl.2021.102882

N/A

0DataRank · unranked

8 citations

Jingwen Yao, Catalina Raymond, Nicholas S. Cho, Richard G. Everson, Kunal Patel +15 more

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Research Square(2021)10.21203/rs.3.rs-793187/v1

N/A

0DataRank · unranked

6 citations

Lu Sun, Aaron Mochizuki, Jeremy Reynoso, Joey Orpilla, Frances Chow +9 more

Worse Prognosis for IDH Wild-Type Diffuse Gliomas With Larger Residual Biological Tumor Burden

Research Square(2021)10.21203/rs.3.rs-148651/v1

N/A

0DataRank · unranked

1 citations

Hiroyuki Uetani, Akifumi Hagiwara, Shadfar Bahri, Catalina Raymond, Albert Lai +7 more

Preferential Tumor Localization in Relation to 18F-FDOPA Uptake for Lower-Grade Gliomas

Research Square(2021)10.21203/rs.3.rs-186583/v1

N/A

0DataRank · unranked

0 citations

Hiroyuki Uetani, Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda +10 more

Federated learning enables big data for rare cancer boundary detection

Nature Communications(2022)10.1038/s41467-022-33407-5

N/A

0DataRank · unranked

352 citations

Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih‐Han Wang, G. Anthony Reina +95 more

Synthesizing MR Image Contrast Enhancement Using 3D High-Resolution ConvNets

IEEE Transactions on Biomedical Engineering(2022)10.1109/tbme.2022.3192309

N/A

0DataRank · unranked

70 citations

Catalina Raymond, William Speier, Xinyu Jin, Timothy F. Cloughesy, Dieter R. Enzmann +3 more

Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4064

N/A

0DataRank · unranked

44 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Neuro-Oncology(2022)10.1093/neuonc/noac086

N/A

0DataRank · unranked

23 citations

Elizabeth R. Gerstner, Andrew B. Lassman, Caroline Chung, Howard Colman, Patricia E. Cole +21 more

Daily functioning in glioma survivors: associations with cognitive function, psychological factors and quality of life

CNS Oncology(2022)10.2217/cns-2022-0002

N/A

0DataRank · unranked

21 citations

Lucy Wall, Brandon F Heimberg, Justin Choi, Catalina Raymond, Chencai Wang +5 more

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI

Scientific Reports(2022)10.1038/s41598-022-05077-2

N/A

0DataRank · unranked

19 citations

Hiroyuki Tatekawa, Jingwen Yao, Catalina Raymond, Richard G. Everson, Kunal Patel +9 more

Prognostic value of O6-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac030

N/A

0DataRank · unranked

14 citations

Blaine S.C. Eldred, Bryan M. Kevan, Sean T. Pianka, Brittany A Eldred, Serendipity Zapanta Rinonos +7 more

Amine‐weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors

NMR in Biomedicine(2022)10.1002/nbm.4785

N/A

0DataRank · unranked

14 citations

Akifumi Hagiwara, Jingwen Yao, David A. Nathanson, Robert M. Prins, Chencai Wang +13 more

ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04193-3

N/A

0DataRank · unranked

13 citations

Charles Nock, Xiaobu Ye, Robert Buerki, Susan M. Chang, Glenn J. Lesser +12 more

Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04123-3

N/A

0DataRank · unranked

12 citations

Ricky R. Savjani, Nicholas S. Cho, Henrik Ullman, Akifumi Hagiwara, Catalina Raymond +9 more

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac124

N/A

0DataRank · unranked

10 citations

Akifumi Hagiwara, Blaine S.C. Eldred, Catalina Raymond, Chencai Wang, Francesco Sanvito +8 more

Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease

Frontiers in Oncology(2022)10.3389/fonc.2022.849993

N/A

0DataRank · unranked

5 citations

Akifumi Hagiwara, Jingwen Yao, Catalina Raymond, Christian Ong, Rojin Bakhti +17 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131

N/A

0DataRank · unranked

154 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more

SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells

Cell Reports(2023)10.1016/j.celrep.2023.112790

N/A

0DataRank · unranked

66 citations

Yaogang Zhong, Huali Su, Étienne Lefai, Shino Magaki, Timothy F. Cloughesy +4 more

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8

N/A

0DataRank · unranked

54 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors

Journal of Clinical Investigation(2023)10.1172/jci169314

N/A

0DataRank · unranked

47 citations

Jenny C. Kienzler, Jeremy Reynoso, Alex Lee, Eileen Shiuan, Shanpeng Li +14 more

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

Neuro-Oncology(2023)10.1093/neuonc/noad002

N/A

0DataRank · unranked

46 citations

Patrick Y. Wen, Susan M. Chang, Martin J. van den Bent, Michael A. Vogelbaum, Gang Li +11 more

Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration

Frontiers in Radiology(2023)10.3389/fradi.2023.1267615

N/A

0DataRank · unranked

28 citations

Timothy J. Kaufmann, Timothy F. Cloughesy, Patrick Y. Wen, Benjamin M. Ellingson, Francesco Sanvito

pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells

Neuro-Oncology(2023)10.1093/neuonc/noad150

N/A

0DataRank · unranked

16 citations

Jingwen Yao, Nicholas S. Cho, Francesco Sanvito, Kaleab Tessema, Alvaro G. Alvarado +9 more

Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI

European Radiology(2023)10.1007/s00330-023-10215-z

N/A

0DataRank · unranked

18 citations

Catalina Raymond, Nicholas S. Cho, Jingwen Yao, Akifumi Hagiwara, Joey Orpilla +9 more

Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3524

N/A

0DataRank · unranked

8 citations

Steffen Ventz, Robert Redd, Timothy F. Cloughesy, Brian M. Alexander, Patrick Y. Wen +2 more

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad084

N/A

0DataRank · unranked

8 citations

Akifumi Hagiwara, Catalina Raymond, Chencai Wang, Nicholas S. Cho, Jianwen Lu +8 more

Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas

Journal of Neuro-Oncology(2023)10.1007/s11060-023-04363-x

N/A

0DataRank · unranked

8 citations

Francesco Sanvito, Shruti Thakuria, Chencai Wang, Akifumi Hagiwara, Raksha Nagaraj +16 more

Retrospective examination of pseudoprogression in IDH mutant gliomas

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad028

N/A

0DataRank · unranked

3 citations

Matthew J. Farrell, Blaine S.C. Eldred, Vicki Liu, Ishan Saha, Serendipity Zapanta Rinonos +13 more

A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad036

N/A

0DataRank · unranked

2 citations

Ethan A. Wetzel, Blaine S.C. Eldred, Serendipity Zapanta Rinonos, Terry J. Prins, Négar Khanlou +7 more

Author Correction: Federated learning enables big data for rare cancer boundary detection

Nature Communications(2023)10.1038/s41467-023-36188-7

N/A

0DataRank · unranked

5 citations

Ujjwal Baid, Brandon Edwards, Micah Sheller, Shih-han Wang, G. Anthony Reina +95 more

Depth of radiographic response (DpR) and time to tumor regrowth (TTG) to predict overall survival following anti-VEGF therapy in recurrent glioblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2063

N/A

0DataRank · unranked

1 citations

Akifumi Hagiwara, Connor J. Morris, Nicholas S. Cho, Sonoko Oshima, Francesco Sanvito +12 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395.v1

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396

N/A

0DataRank · unranked

34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

A brave new framework for glioma drug development

The Lancet Oncology(2024)10.1016/s1470-2045(24)00190-6

N/A

0DataRank · unranked

26 citations

Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse +34 more

D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0271

N/A

0DataRank · unranked

17 citations

Tie Li, Terry J. Prins, Blaine S.C. Eldred, Bryan M. Kevan, Haowen Liang +9 more

Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma

Nature Communications(2024)10.1038/s41467-024-54138-9

N/A

0DataRank · unranked

12 citations

X. Wilson, Kai Song, Nicholas Bayley, Jiyoon Kim, Henan Zhu +15 more

Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction

American Journal of Neuroradiology(2024)10.3174/ajnr.a8094

N/A

0DataRank · unranked

11 citations

Francesco Sanvito, Vien Le, Sonoko Oshima, Ashley Teraishi, Jingwen Yao +9 more

RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice

Current Opinion in Oncology(2024)10.1097/cco.0000000000001077

N/A

0DataRank · unranked

9 citations

Antonella Castellano, Timothy F. Cloughesy, Patrick Y. Wen, Benjamin M. Ellingson, Francesco Sanvito

Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas

Neuroradiology(2024)10.1007/s00234-024-03475-z

N/A

0DataRank · unranked

5 citations

Francesco Sanvito, Vien Le, Sonoko Oshima, Ashley Teraishi, Jingwen Yao +9 more

Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma

CNS Oncology(2024)10.1080/20450907.2024.2415285

N/A

0DataRank · unranked

2 citations

Jingwen Yao, Samuel Bobholz, Raksha Nagaraj, Catalina Raymond, Ashley Teraishi +13 more

“Synthetic” DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging

American Journal of Neuroradiology(2024)10.3174/ajnr.a8475

N/A

0DataRank · unranked

2 citations

Jingwen Yao, Nicholas S. Cho, Catalina Raymond, Donatello Telesca, Whitney B. Pope +6 more

CTNI-66. IDH-MUTANT GLIOMA PATIENTS TREATED WITH VORASIDENIB: ONGOING DATA FROM THE VORASIDENIB EXPANDED ACCESS PROGRAM

Neuro-Oncology(2024)10.1093/neuonc/noae165.0433

N/A

0DataRank · unranked

1 citations

Katherine B. Peters, Howard Colman, Jennie Taylor, Ingo K. Mellinghoff, Helen A. Shih +4 more

Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma

American Journal of Neuroradiology(2024)10.3174/ajnr.a8327

N/A

0DataRank · unranked

0 citations

Chencai Wang, Kathleen Van Dyk, Francesco Sanvito, Sonoko Oshima, Jingwen Yao +6 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118

N/A

0DataRank · unranked

8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma

Current Oncology(2025)10.3390/curroncol32100541

N/A

0DataRank · unranked

4 citations

Kent C. Shih, Pierre Giglio, Howard Colman, Patrick Y. Wen, Jian Campian +6 more

Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumors

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05105-x

N/A

0DataRank · unranked

3 citations

Francesco Sanvito, Jingwen Yao, Sonoko Oshima, Samuel Bobholz, Ashley Teraishi +12 more

Super-resolution sodium MRI of human gliomas at 3T using physics-based generative artificial intelligence

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05094-x

N/A

0DataRank · unranked

2 citations

Jingwen Yao, Alfredo L. Lopez Kolkovsky, Thorsten Feiweier, Bryan Clifford, Heiko Meyer +12 more

Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05019-8

N/A

0DataRank · unranked

1 citations

Irina Kryukov, Jingwen Yao, Ashley Teraishi, Catalina Raymond, John Gao +13 more

Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas

Neuro-Oncology(2025)10.1093/neuonc/noaf171

N/A

0DataRank · unranked

1 citations

Vien Le, Ashley Teraishi, Vicki Liu, Francesco Sanvito, Donatello Telesca +11 more

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Neuro-Oncology(2020)10.1093/neuonc/noaa141

N/A

0DataRank · unranked

195 citations

C. Chad Quarles, Leland Hu, Bradley J. Erickson, Elizabeth R. Gerstner, Marion Smits +26 more

A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf022

N/A

0DataRank · unranked

1 citations

Quincy Okobi, Robert Chong, Rhea Plawat, Eva Zhao, Andrei Gafita +13 more

Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids

iScience(2020)10.1016/j.isci.2020.101569

N/A

0DataRank · unranked

109 citations

Feng Geng, Xiang Cheng, Qiang Guo, Yaogang Zhong, Timothy F. Cloughesy +4 more

Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment

Neuro-Oncology(2020)10.1093/neuonc/noaa105

N/A

0DataRank · unranked

52 citations

Robert J. Young, Benjamin M. Ellingson, Harini Veeraraghavan, Wei Wang, Florent Tixier +12 more

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy

Neuro-Oncology(2020)10.1093/neuonc/noaa154

N/A

0DataRank · unranked

57 citations

Timothy F. Cloughesy, Marcela V. Maus, Robert M. Prins, David A. Reardon, Adam M. Sonabend +1 more

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa124

N/A

0DataRank · unranked

22 citations

John G. Kuhn, Kathleen R. Lamborn, Lauren E. Abrey, Lisa M. DeAngelis, Frank S. Lieberman +14 more

Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden

Neurosurgery(2020)10.1093/neuros/nyaa135

N/A

0DataRank · unranked

22 citations

Richard G. Everson, Jingwen Yao, Catalina Raymond, J.W. Goldman, Jacob Schlossman +11 more

Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma

Scientific Reports(2020)10.1038/s41598-020-71799-w

N/A

0DataRank · unranked

20 citations

Jingwen Yao, Catalina Raymond, William H. Yong, Richard G. Everson, Linda M. Liau +10 more

Timothy F. Cloughesy

Indexed papers

Top data-sharing exemplar

Papers